Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Baxter
Dow
Colorcon
AstraZeneca

Last Updated: April 8, 2020

DrugPatentWatch Database Preview

Tranylcypromine sulfate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for tranylcypromine sulfate and what is the scope of patent protection?

Tranylcypromine sulfate is the generic ingredient in two branded drugs marketed by Concordia, Cnty Line Pharms, and Par Pharm, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for tranylcypromine sulfate. Five suppliers are listed for this compound.

Summary for tranylcypromine sulfate
US Patents:0
Tradenames:2
Applicants:3
NDAs:3
Drug Master File Entries: 6
Suppliers / Packagers: 5
DailyMed Link:tranylcypromine sulfate at DailyMed
Pharmacology for tranylcypromine sulfate
Medical Subject Heading (MeSH) Categories for tranylcypromine sulfate

US Patents and Regulatory Information for tranylcypromine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cnty Line Pharms TRANYLCYPROMINE SULFATE tranylcypromine sulfate TABLET;ORAL 206856-001 Apr 17, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Concordia PARNATE tranylcypromine sulfate TABLET;ORAL 012342-003 Aug 16, 1985 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Par Pharm TRANYLCYPROMINE SULFATE tranylcypromine sulfate TABLET;ORAL 040640-001 Jun 29, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Baxter
Dow
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.